ASX - By Stock
|
LDX |
Re:
Ann: Lumos announces positive FebriDx paediatric study results
|
|
Mani86
|
40 |
6.4K |
8 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
40
|
6.4K
|
8
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Mani86
|
1.5K |
320K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.5K
|
320K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Mani86
|
545 |
214K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
545
|
214K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Mani86
|
5.0K |
2.5M |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.0K
|
2.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Mani86
|
551 |
197K |
7 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
551
|
197K
|
7
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Change in substantial holding
|
|
Mani86
|
26 |
4.0K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
26
|
4.0K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Appoints Henry Schein as US Distributor for FebriDx
|
|
Mani86
|
139 |
27K |
1 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
139
|
27K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
Mani86
|
168 |
96K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
168
|
96K
|
3
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Appoints Henry Schein as US Distributor for FebriDx
|
|
Mani86
|
139 |
27K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
139
|
27K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Mani86
|
1.1K |
320K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.1K
|
320K
|
7
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Appoints Henry Schein as US Distributor for FebriDx
|
|
Mani86
|
139 |
27K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
139
|
27K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Mani86
|
17K |
6.6M |
7 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
17K
|
6.6M
|
7
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Mani86
|
1.5K |
320K |
2 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
1.5K
|
320K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Mani86
|
1.5K |
320K |
0 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
1.5K
|
320K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
Mani86
|
154 |
45K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
45K
|
6
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Change in substantial holding
|
|
Mani86
|
83 |
12K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
83
|
12K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Mani86
|
549 |
170K |
9 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
170K
|
9
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Appoints Henry Schein as US Distributor for FebriDx
|
|
Mani86
|
139 |
27K |
3 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
139
|
27K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
Mani86
|
168 |
96K |
6 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
168
|
96K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
Mani86
|
168 |
96K |
16 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
168
|
96K
|
16
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Mani86
|
1.5K |
320K |
0 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
1.5K
|
320K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Mani86
|
1.5K |
320K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.5K
|
320K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Mani86
|
17K |
6.6M |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
17K
|
6.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Mani86
|
9.5K |
2.7M |
6 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
6
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Mani86
|
1.5K |
320K |
0 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
1.5K
|
320K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Mani86
|
272 |
98K |
21 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
272
|
98K
|
21
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Appoints Henry Schein as US Distributor for FebriDx
|
|
Mani86
|
139 |
27K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
139
|
27K
|
3
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Appoints Henry Schein as US Distributor for FebriDx
|
|
Mani86
|
139 |
27K |
5 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
139
|
27K
|
5
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Investor Roadshow Presentation
|
|
Mani86
|
67 |
12K |
1 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
67
|
12K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
Mani86
|
176 |
50K |
5 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
176
|
50K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Mani86
|
9.5K |
2.7M |
11 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Mani86
|
17K |
6.6M |
18 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
17K
|
6.6M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Mani86
|
9.5K |
2.7M |
9 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
9.5K
|
2.7M
|
9
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Investor Roadshow Presentation
|
|
Mani86
|
67 |
12K |
4 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
67
|
12K
|
4
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Investor Roadshow Presentation
|
|
Mani86
|
67 |
12K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
67
|
12K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Investor Roadshow Presentation
|
|
Mani86
|
67 |
12K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
67
|
12K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Investor Roadshow Presentation
|
|
Mani86
|
67 |
12K |
8 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
67
|
12K
|
8
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mani86
|
44 |
8.5K |
5 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
44
|
8.5K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mani86
|
102 |
37K |
7 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
102
|
37K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Mani86
|
17K |
6.6M |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
17K
|
6.6M
|
3
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mani86
|
44 |
8.5K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
44
|
8.5K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mani86
|
44 |
8.5K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
44
|
8.5K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Mani86
|
380 |
126K |
2 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
380
|
126K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Mani86
|
380 |
126K |
10 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
380
|
126K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Mani86
|
380 |
126K |
15 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
380
|
126K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Mani86
|
380 |
126K |
8 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
126K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Mani86
|
362 |
116K |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
362
|
116K
|
3
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Mani86
|
1.5K |
320K |
7 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
1.5K
|
320K
|
7
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Investor Briefing on new Hologic Agreements
|
|
Mani86
|
121 |
22K |
3 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
121
|
22K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Mani86
|
17K |
6.6M |
9 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|